Land: Canada
Språk: engelsk
Kilde: Health Canada
CLOXACILLIN (CLOXACILLIN SODIUM)
STERIMAX INC
J01CF02
CLOXACILLIN
500MG
POWDER FOR SOLUTION
CLOXACILLIN (CLOXACILLIN SODIUM) 500MG
INTRAMUSCULAR
10
Prescription
PENICILLINASE-RESISTANT PENICILLINS
Active ingredient group (AIG) number: 0131306001; AHFS:
MARKETED
2011-09-14
1 PRESCRIBING INFORMATION PR CLOXACILLIN FOR INJECTION Cloxacillin Powder for Solution (as cloxacillin sodium) 500mg powder/vial 1g powder/vial 2g powder/vial 10g powder/vial STERILE ANTIBIOTIC SteriMax Inc. 2770 Portland Drive, Oakville, ON L6H 6R4 Date of Revision: February 14, 2019 CONTROL NUMBER: 221983 2 TABLE OF CONTENTS PART 1: HEALTH PROFESSIONAL INFORMATION ………………………...... 3 SUMMARY PRODUCT INFORMATION……………………………………... 3 INDICATIONS AND CLINICAL USE………………………………………… 3 CONTRAINDICATIONS………………………………………………………. 3 WARNINGS AND PRECAUTIONS…………………………………………… 4 ADVERSE REACTIONS……………………………………………………….. 5 DRUG INTERACTIONS………………………………………………………... 5 DOSAGE AND ADMINISTRATION………………………………………….. 5 OVERDOSAGE…………………………………………………………………. 7 ACTIONS AND CLINCAL PHARMACOLOGY……………………………… 7 STORAGE AND STABILITY…………………………………………………... 8 DOSAGE FORMS, COMPOSITION AND PACKAGING…………………….. 8 PART II: SCIENTIFIC INFORMATION ................................................................... 9 PHARMACEUTICAL INFORMATION………………….............……............. 9 PART III: CONSUMER INFORMATION .................................................................. 10 3 PRESCRIBING INFORMATION PR CLOXACILLIN FOR INJECTION CLOXACILLIN POWDER FOR SOLUTION (AS CLOXACILLIN SODIUM) PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION ROUTE OF ADMINISTRATION DOSAGE FORM / STRENGTH CLINICALLY RELEVANT NON-MEDICINAL INGREDIENTS IV, IM, IV Infusion Powder for reconstitution for INJECTION None INDICATIONS AND CLINICAL USE The treatment of beta-hemolytic streptococcal and pneumococcal infections as well as staphylococcal infections (inc Les hele dokumentet